The sleep apnea devices market is set to thrive at a steady CAGR of 9.5% during the forecast period. The market holds a share of US$ 8.2 billion in 2023 while it is anticipated to cross a value of US$ 20.4 billion by 2033.
The research report on sleep apnea devices market explains that the inactive lifestyle of youngsters is exploiting them physically and mentally. Furthermore, conditions like sleep apnea have become quite common in the urban setting. This overall lifestyle has turned people obese, unfit, and ill. Thus, the researchers have found solutions for each of these diseases that are connected to the human lifestyle, directly or indirectly. Sleep apnea is a serious condition that serves to severe cases like stroke, heart arrest, and shortness of oxygen. However, the condition has flourished in the market of sleep apnea devices that provide ease and secure the sleep of the affected patient. Some of these devices involve masks, continuous positive airway pressure (CPAP) machines, etc. The end goal is to maintain a fixed amount of air pressure in the mask, so it keeps the upper airway passages open.
The sleep apnea devices market outlook states that the latest technology of upper airway stimulation (UAS) has been added to the upcoming devices. UAS technology treats sleep apnea with stimulation of muscles that control the tongue from collapsing into the airway. The procedure is minimally invasive, and the result is positive air breathing. Demand for sleep apnea devices is expected to positively drive the market over the forecast period, owing to the focus of extensive research and development by manufacturers to support the healthcare sector with prominent offerings. Through campaigns like 'sleep awareness week,' various organizations and government agencies are focusing on raising awareness and diagnosis rates among these patients, and the market has been expanding at a steady rate.
| Attributes | Details |
|---|---|
| Sleep Apnea Devices Market CAGR (2023 to 2033) | 9.5% |
| Sleep Apnea Devices Market Size (2023) | US$ 8.2 billion |
| Sleep Apnea Devices Market Size (2033) | US$ 20.4 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Short-term Growth: From 2017 to 2022, the global sleep apnea devices market registered a comparatively higher CAGR of 6.8%. Technological advancement is expected to propel the demand for sleep apnea devices during the forecast period. Players in the industry are concentrating their efforts on research and development to create innovative technologies. For example, ResMed introduced AirMini, the world's smallest PAP device that is linked to the AirView remote patient monitoring platform.
Mid-term Growth: Patients can view their data on their phones thanks to this device. As a result, the commercialization of such advanced devices hastens the sleep apnea devices market statistics in the coming years. Similarly, recently introduced lightweight, portable CPAP machines, combined with pressure-compensating sensors that can compensate for altitude-related drops in atmospheric pressure, are expected to increase the adoption of sleep apnea devices. The market is likely to grow steadily between 2023 and 2028.
Long-term Growth: New devices for sleep apnea are becoming more popular, as they provide patients with more options and flexibility. As a result, the use of technology-enabled sleep apnea devices for diagnostic and treatment purposes in various sleep disorders is expected to peak in the coming years. The sleep apnea devices market is anticipated to thrive at a CAGR of 9.5% between 2023 and 2033.
North America dominated the sleep apnea devices market in 2020, accounting for 49.0% of total sales. The increasing incidence of respiratory illnesses is causing some sleeping disturbance, boosting the sleep apnea devices market.
Furthermore, rising awareness of sleep apnea, a big patient pool, and foreign manufacturers are expected to boost this region's sleep apnea devices market share. Some of the key participants present in North America are Philips Respironics; Somnetics International Inc.; and ResMed.
Moreover, strategic initiatives by key players have also fueled the market growth. For instance, in October 2021, AirAvant Medical introduced a new device called Bongo Rx for the treatment of obstructive sleep apnea (OSA). The device is touted as a continuous positive airway pressure (CPAP) alternative and is clinically proven to treat mild to moderate OSA symptoms.
Principal Consultant
The emergence of new devices, such as pressure-compensating sensors, is predicted to skyrocket the overall market growth.
Manufacturers are working hard for research and development of innovative offerings to serve a large customer base, and that may allow the sleep apnea devices market to grow. Hence, manufacturers are adopting strategies such as mergers & acquisitions to expand their global footprint and add disruptive packaging advancements to their product portfolio.
Further, several international market participants are entering into acquisitions and mergers and implementing new technology to increase commercial capacity to gain a leading revenue share.
For instance, in August 2021, connected sleep device maker ResMed released the AirSense 11, one of its latest CPAP machine iterations, which includes a host of new features to treat obstructive sleep apnea. The machine has many of the same specs as ResMed’s previous device, the AirSense 10, but also includes exclusive access to new features.
These include device set-up tutorials on the myAir patient engagement app, personalized care guidance, and remote patient monitoring through the AirView platform. It comes equipped with algorithms that deliver breath-by-breath therapy adjustments and provide nightly breathing data, such as the total amount of times a user spends using CPAP therapy, the number of sleep apnea events per hour, mask leaks, and the number of times the mask was removed. AirSense 11 can also make remote software updates.
Despite their high effectiveness, the action efficacy of machines for sleep apnea is limited in several cases because they require precise and consistent use, as well as constant medical supervision, and the same acts as one of the key factors confining sleep apnea devices' market outlook.
The growing awareness of untreated sleep apnea devices markets future trends
The rapidly growing geriatric population suffering from sleep apnea and related health conditions have increased the demand for sleep apnea devices, boosting the sleep apnea device market trends.
The most common sleep-related breathing disorder, obstructive sleep apnea, is associated with a significant disease burden.
Through campaigns like 'sleep awareness week,' various organizations and government agencies are focusing on raising awareness and diagnosis rates among these patients. This is expected to fuel the sleep apnea devices market size even more.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
High CPCP machine price negatively affects the sleep apnea devices market around the globe.
Despite the rising prevalence of the disorder and sedentary lifestyle-related diseases around the world, certain factors are limiting the market's growth. One of them is the high CPAP machine cost.
For OSA treatment, PSG and CPAP machines are the best options. The infrastructure and reimbursement systems in developed countries are well-established.
However, developing countries have poor reimbursement systems and high patient out-of-pocket expenses.
This, combined with the low rate of medical coverage in these countries, is limiting the number of patients who can receive treatment there. The sleep apnea devices market growth is being stifled as a result of this.
Treatment adherence, particularly with CPAP, has always been a challenge for sleep apnea patients.
In the short term, this lack of adherence is expected to be a key impediment to the sleep apnea devices adoption trends. However, in the long run, it may have little impact because manufacturers are focusing on making their products more technologically advanced and reducing the drawbacks associated with their adherence to sleep apnea treatment.
The lack of patient compliance with CPAP therapy is a stumbling block in the market's expansion. This is primarily because of a lack of affordability and comfort.
| Region | Absolute Market Growth |
|---|---|
| United States | US$ 5.6 billion |
| Germany | US$ 367.6 million |
| Japan | US$ 698.8 million |
| China | US$ 534.7 million |
| Australia | US$ 294.7 million |
Rising Cases of Stroke and Obesity in the United States are Booming the Regional Market Growth
| United States Market CAGR (2023 to 2033) | 9.3% |
|---|---|
| United States Market Absolute Doller Growth (US$ million/billion) | US$ 5.6 billion |
United States leads the sleep apnea devices market with a CAGR of 9.3% between 2023 and 2033, while reaching a value of US$ 9.5 billion by 2033. Rising awareness of sleep apnea, a big patient pool, and foreign manufacturers are expected to boost this region's sleep apnea devices market share. Furthermore, the number of therapeutic tests for establishing the presence of sleep apnea in the region is fast increasing, as many people are concerned about the health concerns associated with this illness.
| Region | Attributes |
|---|---|
| Japanese Market CAGR (2023 to 2033) | 8.8% |
| Japanese Market Absolute Doller Growth (US$ million/billion) | US$ 3.2 billion |
Japan sleep apnea devices market is anticipated to flourish at a steady CAGR of 8.9% during the forecast period. The regional market is anticipated to reach a value of US$ 1.2 billion
The sleep apnea devices market in Japan is expected to rise at a rapid pace over the forecast period. The Japanese sleep apnea devices market is being driven by a growing elderly population and an increase in the prevalence of lifestyle illnesses.
According to the WHO, chronic respiratory illnesses, diabetes, cardiovascular diseases, and cancer are some of the top causes of mortality in the region.
According to the IDF Diabetes Atlas 9th Edition, about 87.6 million persons in the South East Asia area are diabetic, ranging in age from 20 to 79 years. With the incidence of chronic diseases on the rise, Japan is projected to see an increase in the use of sleep apnea devices. According to a PubMed study, the prevalence of obstructive sleep apnea in middle-aged Asian men ranges from 4.1% to 7.5% and 2.1% to 3.2% in females.
| Segment | Top Product |
|---|---|
| Top Sub-segment | Therapeutics |
| CAGR (2017 to 2022) | 6.6% |
| CAGR (2023 to 2033) | 9.4% |
| Segment | Top End User |
|---|---|
| Top Sub-segment | Sleep Laboratories & Hospitals |
| CAGR (2017 to 2022) | 6.4% |
| CAGR (2023 to 2033) | 9.1% |
The therapeutic devices category dominated the sleep apnea devices market, based on product. The therapeutic devices category is expected to lead the sleep apnea devices market with a CAGR of 9.4% between 2023 and 2033. Continuous positive airway pressure treatment (CPAP) employs a CPAP machine to assist a person suffering from obstructive sleep apnea (OSA) in breathing more comfortably while sleeping. A CPAP machine raises the pressure in your throat, preventing your airway from collapsing as you breathe in.
The sleep laboratories and hospitals sector held the greatest proportion of the sleep apnea devices market. The higher consumption and extended research facilities are making this end-user segment the fast-growing segment in the market. Government spending big chunks on healthcare advancement and techniques are also thriving the sales of sleep apnea devices. The segment thrives at a steady CAGR of 9.1% between 2023 and 2033.
Key businesses like ResMed, Philips Respironics, and Somnetics International, Inc. have built a significant presence in the region, as well as strong distribution networks to ensure a simple supply of their goods.
The fierce rivalry among sleep apnea devices market competitors to extend their regional footprints and increase their client pool through multiple product releases and new product innovations is expected to drive the sleep apnea devices market over the projected period.
Market Developments
The sleep apnea devices market holds a valuation of US$ 8.2 billion in 2023.
The projected value of the sleep apnea devices market is anticipated to attain US$ 20.4 billion by 2033.
The sleep apnea devices market is anticipated to register a CAGR of 9.5% through 2033.
The sleep apnea devices market in the United States is poised for lucrative growth, targeting a US$ 5.6 billion market size by 2033 with a robust 9.3% CAGR.
The global demand for sleep apnea devices experienced a CAGR of 6.8% between 2018 and 2022.
1. Executive Summary | Sleep Apnea Devices Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2017 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Therapeutics
5.3.1.1. Airway Clearance Systems
5.3.1.2. Adaptive Servo-ventilation
5.3.1.3. Positive Airway Pressure Device
5.3.1.4. Oral Appliances
5.3.1.5. Oxygen Devices
5.3.1.6. Others
5.3.2. Diagnostics
5.3.2.1. Actigraphy Systems
5.3.2.2. Polysomnography Device
5.3.2.3. Respiratory Polygraph
5.3.2.4. Sleep Screening Devices
5.4. Y-o-Y Growth Trend Analysis By Product, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
6.3.1. Home Care Settings & Individuals
6.3.2. Sleep Laboratories & Hospitals
6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Product
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By End User
9.4. Key Takeaways
10. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. United Kingdom
10.2.1.2. Spain
10.2.1.3. Germany
10.2.1.4. Italy
10.2.1.5. France
10.2.1.6. Rest of Europe
10.2.2. By Product
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By End User
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. India
11.2.1.2. China
11.2.1.3. Japan
11.2.1.4. Australia
11.2.1.5. Rest of Asia Pacific
11.2.2. By Product
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By End User
11.4. Key Takeaways
12. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. South Africa
12.2.1.2. GCC Countries
12.2.1.3. Rest of Middle East and Africa
12.2.2. By Product
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By End User
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. USA
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2022
13.1.2.1. By Product
13.1.2.2. By End User
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2022
13.2.2.1. By Product
13.2.2.2. By End User
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2022
13.3.2.1. By Product
13.3.2.2. By End User
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2022
13.4.2.1. By Product
13.4.2.2. By End User
13.5. United Kingdom
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2022
13.5.2.1. By Product
13.5.2.2. By End User
13.6. Spain
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2022
13.6.2.1. By Product
13.6.2.2. By End User
13.7. Germany
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2022
13.7.2.1. By Product
13.7.2.2. By End User
13.8. Italy
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2022
13.8.2.1. By Product
13.8.2.2. By End User
13.9. France
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2022
13.9.2.1. By Product
13.9.2.2. By End User
13.10. India
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2022
13.10.2.1. By Product
13.10.2.2. By End User
13.11. China
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2022
13.11.2.1. By Product
13.11.2.2. By End User
13.12. Japan
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2022
13.12.2.1. By Product
13.12.2.2. By End User
13.13. Australia & New Zealand
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2022
13.13.2.1. By Product
13.13.2.2. By End User
13.14. South Africa
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2022
13.14.2.1. By Product
13.14.2.2. By End User
13.15. GCC Countries
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2022
13.15.2.1. By Product
13.15.2.2. By End User
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Product
14.3.3. By End User
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. BMC Medical Co., Ltd.
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. LivaNova PLC
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Cadwell Laboratories Inc.
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Fisher & Paykel Healthcare
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Invacare Corporation
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. Itamar Medical Ltd
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. Natus Medical Inc.
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. Nihon Kohden
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. Koninklijke Philips N.V.
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.10. ResMed Inc.
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
15.1.11. Teleflex Inc.
15.1.11.1. Overview
15.1.11.2. Product Portfolio
15.1.11.3. Profitability by Market Segments
15.1.11.4. Sales Footprint
15.1.11.5. Strategy Overview
15.1.11.5.1. Marketing Strategy
15.1.12. Drive DeVilbiss International
15.1.12.1. Overview
15.1.12.2. Product Portfolio
15.1.12.3. Profitability by Market Segments
15.1.12.4. Sales Footprint
15.1.12.5. Strategy Overview
15.1.12.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Explore Healthcare Insights
View Reports
Sleep Apnea Devices Market
